•
AB
ABVC
ABVC BioPharma, Inc. Common Stock
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
52.25M
Volume
76.48K
52W High
$5.48
52W Low
$0.40
Open
$2.15
Prev Close
$2.15
Day Range
2.03 - 2.19
About ABVC BioPharma, Inc. Common Stock
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Latest News
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
GlobeNewswire Inc.•Apr 18
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
GlobeNewswire Inc.•Mar 26
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
GlobeNewswire Inc.•Mar 14
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
GlobeNewswire Inc.•Feb 8
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga•Jan 4
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Benzinga•Jan 4
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga•Jan 3
ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees
GlobeNewswire Inc.•Jan 3